2370.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 05:36):

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan...

Stats
Dagens volum	109 900
Gjennomsnittsvolum	1.44M
Markedsverdi	11.53B
EPS	¥0 ( 2024-02-08 )
Neste inntjeningsdato	( ¥0 ) 2024-05-08
Last Dividend	¥0 ( N/A )
Next Dividend	¥0 ( N/A )
P/E	-7.13
ATR14	¥0.346 (0.77%)

Volum Korrelasjon

Lang: 0.13 (neutral)

Kort: -0.75 (moderate negative)

Signal:(43.453) Neutral

MEDINET Co., Ltd. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

MEDINET Co., Ltd. Korrelasjon - Valuta/Råvare

0.51
( weak )

0.40
( neutral )

0.23
( neutral )

0.38
( neutral )

-0.34
( neutral )

MEDINET Co., Ltd. Økonomi

Annual	2023
Omsetning:	¥661.54M
Bruttogevinst:	¥98.25M (14.85 %)
EPS:	¥-6.65

FY	2023
Omsetning:	¥661.54M
Bruttogevinst:	¥98.25M (14.85 %)
EPS:	¥-6.65

FY	2022
Omsetning:	¥633.67M
Bruttogevinst:	¥127.92M (20.19 %)
EPS:	¥-6.33

FY	2021
Omsetning:	¥683.03M
Bruttogevinst:	¥180.42M (26.41 %)
EPS:	¥-6.20

Financial Reports:

No articles found.

MEDINET Co., Ltd.

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy. The company also manufactures regenerative medical/investigational and specified cell products. In addition, its value chain solutions include personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. Further, the company supports medical institutions, research institutions, and biopharmaceutical companies to conduct immuno-cell therapy. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.